This study is currently not recruiting participants.

Development of a urine assay for detection of bladder renal and prostate cancer based on mutational alterations urine based protein markers and the genomic landscape in genitourinary oncology

Investigation of Tumor DNA Detection in Urine for Cancer Patients

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to demonstrate if an assay can detect tumor DNA in urine from patients known to have either bladder, renal, or prostate cancer.

Detailed description of study

The purpose of this study is to demonstrate if an assay can detect tumor DNA in urine from patients known to have either bladder, renal, or prostate cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: bladder cancer,renal cancer,prostate cancer
  • Age: 18 years - 100 years
  • Gender: All

This study investigates the ability of a test, called an assay, to find tumor DNA in the urine of patients who have bladder, renal, or prostate cancer. Tumor DNA is genetic material that comes from cancer cells. The study aims to see if this test can accurately detect the presence of cancer by analyzing urine samples.

Participants in the study will provide urine samples, which will be tested using the assay to check for tumor DNA. The assay is a type of test that looks for specific DNA markers that are associated with cancer cells. This process helps researchers understand if the assay can be a useful tool for detecting cancer through urine.

  • Who can participate: Participants must be known to have bladder, renal, or prostate cancer. There are no age criteria specified, confirming no age restrictions for participation.
  • Study details: Participants will be required to provide urine samples for testing. These samples will be analyzed to detect tumor DNA using the assay.
Updated on 19 Feb 2024. Study ID: 1601493551 (IUSCC-0572)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team